NCT00696423View on ClinicalTrials.gov

Immunogenicity and Safety of GSK Biologicals' Infanrix/Hib in Children

PHASE3CompletedINTERVENTIONAL
Enrollment

467

Participants

Timeline

Start Date

June 7, 2008

Primary Completion Date

July 26, 2008

Study Completion Date

July 26, 2008

Conditions
Acellular PertussisDiphtheriaTetanus
Interventions
BIOLOGICAL

Infanrix™

Intramuscular injection, one dose

BIOLOGICAL

Hiberix™

Intramuscular injection, one dose

Trial Locations (3)

545200

GSK Investigational Site, Liucheng County

Unknown

GSK Investigational Site, Mengshan

GSK Investigational Site, Wuzhou

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY